Literature DB >> 11340331

(S)-albuterol increases the production of histamine and IL-4 in mast cells.

S H Cho1, J Y Hartleroad, C K Oh.   

Abstract

BACKGROUND: Racemic albuterol is an equimolar mixture of (R)-albuterol and (S)-albuterol. Previous studies indicated that (S)-albuterol may exert proinflammatory effects. We investigated the effect of (S)-albuterol in the production of mast cell mediators such as histamine and interleukin (IL)-4.
METHODS: Murine mast cells were either unstimulated or stimulated by IgE-receptor crosslinking. Both groups of mast cells were pretreated with either (R)- or (S)-albuterol. Histamine release and IL-4 secretion were measured by ELISA. Expression of L-histidine decarboxylase (L-HDC) and IL-4 was analyzed by semiquantitative reverse transcription-polymerase chain reaction.
RESULTS: In the overnight IgE-stimulated group, secreted histamine and total histamine were approximately 19.9 and 18.3% greater in cells co-treated with (S)-albuterol than untreated cells, respectively (n = 4, p < 0.002, p < 0.02), whereas there was no significant difference between the cells treated with (R)-albuterol and untreated cells. When the IgE-stimulated cells were treated with (S)-albuterol for 6 and 24 h, histamine release was approximately 18.3 and 24% greater, respectively (n = 4, p < 0.01). L-HDC is an essential enzyme for synthesizing histamine and its message was significantly induced in mast cells treated with (S)-albuterol. Both IL-4 message and protein were also significantly increased after treatment with (S)-albuterol. In the overnight IgE-stimulated group, IL-4 secretion was increased by approximately 58.8% upon exposure to (S)-albuterol (n = 5, p < 0.01). (R)-albuterol had no effect on mast cell mediator release.
CONCLUSION: (S)-albuterol may have adverse effects in asthma control by activating mast cells to produce inflammatory mediators such as histamine and IL-4. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340331     DOI: 10.1159/000053783

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

1.  (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS.

Authors:  Brian N Chorley; Yuehua Li; Shijing Fang; Jin-Ah Park; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-29       Impact factor: 6.914

Review 2.  Beta2-agonists and bronchial hyperresponsiveness.

Authors:  Clive P Page; Domenico Spina
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

3.  Asthma treatment through the beta receptor: lessons from animal models.

Authors:  Erik P Riesenfeld; Charles G Irvin
Journal:  Front Biosci (Elite Ed)       Date:  2011-06-01

4.  Levosalbutamol vs racemic salbutamol in the treatment of acute exacerbation of asthma.

Authors:  Ajay Punj; Ashish Prakash; Ashu Bhasin
Journal:  Indian J Pediatr       Date:  2009-11       Impact factor: 1.967

5.  Levalbuterol versus albuterol.

Authors:  Bill T Ameredes; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

6.  Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma.

Authors:  Lennart K A Lundblad; Lisa M Rinaldi; Matthew E Poynter; Erik P Riesenfeld; Min Wu; Steven Aimi; Leesa M Barone; Jason H T Bates; Charles G Irvin
Journal:  Respir Res       Date:  2011-03-07

Review 7.  Evidence based review on levosalbutamol.

Authors:  Mukesh Kumar Gupta; Meenu Singh
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 5.319

8.  Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing.

Authors:  John F Freiler; Rajiv Arora; Thomas C Kelley; Larry Hagan; Patrick F Allan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 9.  Single-isomer levalbuterol: a review of the acute data.

Authors:  Richard Nowak
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

10.  An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation.

Authors:  Xuemei Zhang; Qing Liu; Junhua Hu; Ling Xu; Wen Tan
Journal:  Acta Pharm Sin B       Date:  2014-01-18       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.